Toolkit Overview
Today’s health benefits professional needs to make critical and informed decisions to better manage the higher cost of specialty drugs inclusive of biopharma drugs and solutions (i.e. biologics, biosimilars, pharmacogenomics, gene therapies).
This toolkit provides guidance, knowledge and access to no-cost resources to support plan performance and cost management efforts, and includes ways to optimize specialty drug use in the medical and pharmacy benefit, make informed decisions on benefit coverage approaches and address PBM transparency issues on pricing, rebates and contracting.
Click here to view this new full report
New Report on Authorized Generics
The Role of Biosimilars a New MBGH Report
Click here to view the full report
Click here to view: National Alliance 2020 Employer Rx Value Report
Click here to access no-cost tools & resources
Click here to view employers' views on the impact of specialty drugs
Click here to view the article: Resolving to Control Drug Costs
Click here to view the article: Resolving to Control Drug Costs
2021 Action Brief: Car T-Cell Therapy
The last several years have seen significant growth in the number and utilization of specialty drugs. Cancer immunotherapy, in particular, …
2020 Employer RX Value
This report from the National Alliance of Healthcare Purchasers offers insights and a framework for employers on how they can …
Resolving to Control Drug Costs
Denise Giambalvo, MBGH Vice President, shares five actions employers can take to create savings for their pharmacy benefits plan and …